170 related articles for article (PubMed ID: 34294686)
1. Afatinib induces pro-survival autophagy and increases sensitivity to apoptosis in stem-like HNSCC cells.
Liu X; Suo H; Zhou S; Hou Z; Bu M; Liu X; Xu W
Cell Death Dis; 2021 Jul; 12(8):728. PubMed ID: 34294686
[TBL] [Abstract][Full Text] [Related]
2. Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells.
Macha MA; Rachagani S; Qazi AK; Jahan R; Gupta S; Patel A; Seshacharyulu P; Lin C; Li S; Wang S; Verma V; Kishida S; Kishida M; Nakamura N; Kibe T; Lydiatt WM; Smith RB; Ganti AK; Jones DT; Batra SK; Jain M
Oncotarget; 2017 Mar; 8(13):20961-20973. PubMed ID: 28423495
[TBL] [Abstract][Full Text] [Related]
3. Neferine promotes the apoptosis of HNSCC through the accumulation of p62/SQSTM1 caused by autophagic flux inhibition.
Zhu F; Li X; Tang X; Jiang J; Han Y; Li Y; Ma C; Liu Z; He Y
Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 33982791
[TBL] [Abstract][Full Text] [Related]
4. Blocking autophagy improves the anti-tumor activity of afatinib in lung adenocarcinoma with activating EGFR mutations in vitro and in vivo.
Hu X; Shi S; Wang H; Yu X; Wang Q; Jiang S; Ju D; Ye L; Feng M
Sci Rep; 2017 Jul; 7(1):4559. PubMed ID: 28676644
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
6. Autophagy blockade sensitizes human head and neck squamous cell carcinoma towards CYT997 through enhancing excessively high reactive oxygen species-induced apoptosis.
Gao L; Zhao X; Lang L; Shay C; Andrew Yeudall W; Teng Y
J Mol Med (Berl); 2018 Sep; 96(9):929-938. PubMed ID: 30022281
[TBL] [Abstract][Full Text] [Related]
7. Blocking autophagy flux promotes interferon-alpha-mediated apoptosis in head and neck squamous cell carcinoma.
Yang W; Jiang C; Xia W; Ju H; Jin S; Liu S; Zhang L; Ren G; Ma H; Ruan M; Hu J
Cancer Lett; 2019 Jun; 451():34-47. PubMed ID: 30862487
[TBL] [Abstract][Full Text] [Related]
8. Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC.
Nakamura Y; Togashi Y; Nakahara H; Tomida S; Banno E; Terashima M; Hayashi H; de Velasco MA; Sakai K; Fujita Y; Okegawa T; Nutahara K; Hamada S; Nishio K
Mol Cancer Ther; 2016 Aug; 15(8):1988-97. PubMed ID: 27207775
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous targeting of EGFR, HER2, and HER4 by afatinib overcomes intrinsic and acquired cetuximab resistance in head and neck squamous cell carcinoma cell lines.
De Pauw I; Lardon F; Van den Bossche J; Baysal H; Fransen E; Deschoolmeester V; Pauwels P; Peeters M; Vermorken JB; Wouters A
Mol Oncol; 2018 Jun; 12(6):830-854. PubMed ID: 29603584
[TBL] [Abstract][Full Text] [Related]
11. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
Xie J; Li Q; Ding X; Gao Y
Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
[TBL] [Abstract][Full Text] [Related]
12. ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.
Zhang Z; Liu R; Shuai Y; Huang Y; Jin R; Wang X; Luo J
Br J Cancer; 2020 Jan; 122(1):82-93. PubMed ID: 31819178
[TBL] [Abstract][Full Text] [Related]
13. Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma.
An JS; Moon JH; Kim C; No JK; Eun YG; Chang Lim Y
Exp Cell Res; 2021 Oct; 407(2):112815. PubMed ID: 34496296
[TBL] [Abstract][Full Text] [Related]
14. Dihydromyricetin promotes autophagy and apoptosis through ROS-STAT3 signaling in head and neck squamous cell carcinoma.
Fan TF; Wu TF; Bu LL; Ma SR; Li YC; Mao L; Sun ZJ; Zhang WF
Oncotarget; 2016 Sep; 7(37):59691-59703. PubMed ID: 27474168
[TBL] [Abstract][Full Text] [Related]
15. A new gamboge derivative compound 2 inhibits cancer stem-like cells via suppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma.
Deng R; Wang X; Liu Y; Yan M; Hanada S; Xu Q; Zhang J; Han Z; Chen W; Zhang P
J Cell Mol Med; 2013 Nov; 17(11):1422-33. PubMed ID: 24112466
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone induces cell death in human squamous carcinoma cells via caspase activation-dependent apoptosis and LC3-II activation-dependent autophagy.
Chu SC; Hsieh YS; Yu CC; Lai YY; Chen PN
PLoS One; 2014; 9(7):e101579. PubMed ID: 25000169
[TBL] [Abstract][Full Text] [Related]
17. Celastrol acts synergistically with afatinib to suppress non-small cell lung cancer cell proliferation by inducing paraptosis.
Dai CH; Zhu LR; Wang Y; Tang XP; Du YJ; Chen YC; Li J
J Cell Physiol; 2021 Jun; 236(6):4538-4554. PubMed ID: 33230821
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting ROS-NF-κB-dependent autophagy enhanced brazilin-induced apoptosis in head and neck squamous cell carcinoma.
He ZJ; Zhu FY; Li SS; Zhong L; Tan HY; Wang K
Food Chem Toxicol; 2017 Mar; 101():55-66. PubMed ID: 28063998
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib and Afatinib Show Potential Efficacy for Fanconi Anemia-Related Head and Neck Cancer.
Montanuy H; Martínez-Barriocanal Á; Antonio Casado J; Rovirosa L; Ramírez MJ; Nieto R; Carrascoso-Rubio C; Riera P; González A; Lerma E; Lasa A; Carreras-Puigvert J; Helleday T; Bueren JA; Arango D; Minguillón J; Surrallés J
Clin Cancer Res; 2020 Jun; 26(12):3044-3057. PubMed ID: 32005748
[TBL] [Abstract][Full Text] [Related]
20. Tumor growth suppression by inhibiting both autophagy and STAT3 signaling in HNSCC.
Fan TF; Bu LL; Wang WM; Ma SR; Liu JF; Deng WW; Mao L; Yu GT; Huang CF; Liu B; Zhang WF; Sun ZJ
Oncotarget; 2015 Dec; 6(41):43581-93. PubMed ID: 26561201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
